EuBiologics Co., Ltd. (KOSDAQ:206650)

South Korea flag South Korea · Delayed Price · Currency is KRW
8,890.00
+660.00 (8.02%)
Jun 29, 2026, 3:30 PM KST
Market Cap326.47B -31.6%
Revenue (ttm)96.04B +62.4%
Net Income24.87B
EPSn/a
Shares Out 36.72M
PE Ratio13.13
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume179,358
Open8,020.00
Previous Close8,230.00
Day's Range8,020.00 - 8,900.00
52-Week Range8,010.00 - 17,700.00
Beta0.18
Analystsn/a
Price Targetn/a
Earnings DateApr 3, 2026

About EuBiologics

EuBiologics Co., Ltd., a biopharmaceutical company, focuses on developing vaccines against global pandemic and bacterial vaccines primarily in South Korea. It offers inactivated oral cholera vaccine under the Euvichol, Euvichol-Plus, and Euvichol-S names; and EuCorVac-19, a recombinant protein vaccine. The company also provides EcML that is used as a vaccine adjuvant, directly activating antigen presenting cell expressing TLR 4 agonist, stimulating the production of cytokines and co-stimulatory molecules. In addition, it offers carrier protein ... [Read more]

Sector Healthcare
Founded 2010
Country South Korea
Stock Exchange KOSDAQ
Ticker Symbol 206650
Full Company Profile

Financial Performance

Financial Statements